{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:21:20Z","timestamp":1792592480188,"version":"4.5.0"},"reference-count":53,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T00:00:00Z","timestamp":1714953600000},"content-version":"unspecified","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,3,7]]},"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To determine the association of non-alcoholic fatty liver disease (NAFLD) with the incidence of sarcopenia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Systematic review and meta-analysis of observational clinical studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting and participants<\/jats:title>\n                    <jats:p>Adults with NAFLD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Databases such as PubMed, Embase, Cochrane and Web of Science were searched for eligible studies published from the inception of each database up to 4 April 2023. All cross-sectional studies on the association between NAFLD and sarcopenia were included in this study. The quality of the included studies and risk of bias was assessed using the Agency for Healthcare Research and Quality checklist. STATA V.15.1 software was used for statistical analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 1524 retrieved articles, 24 were included in this review, involving 88\u2009609 participants. Our findings showed that the prevalence of sarcopenia was higher in the NAFLD group than in the control group (pooled OR 1.74, 95%\u2009CI 1.39 to 2.17). In a subgroup analysis by region, patients with NAFLD showed an increased risk of sarcopenia (pooled OR 1.97, 95%\u2009CI 1.54 to 2.51) in the Asian group, whereas patients with NAFLD had no statistically significant association with the risk of sarcopenia in the American and European groups, with a pooled OR of 1.31 (95% CI 0.71 to 2.40) for the American group and a pooled OR of 0.99 (95% CI 0.21 to 4.69) for the European group. Similar results were observed in the sensitivity analysis, and no evidence of publication bias was observed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and implications<\/jats:title>\n                    <jats:p>The current study indicated a significant positive correlation between NAFLD and sarcopenia, which may be affected by regional factors. This study provides the correlation basis for the relationship between NAFLD and sarcopenia and helps to find the quality strategy of sarcopenia targeting NAFLD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2023-078933","type":"journal-article","created":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T14:13:52Z","timestamp":1715004832000},"page":"e078933","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":17,"title":["Association between non-alcoholic fatty liver disease and risk of sarcopenia: a systematic review and meta-analysis"],"prefix":"10.1136","volume":"14","author":[{"given":"Chao","family":"Deng","sequence":"first","affiliation":[{"name":"Department of Orthopedics, Hand and Microsurgery, Xiangya Hospital Central South University, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifeng","family":"Ou","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Hand and Microsurgery, Xiangya Hospital Central South University, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuee","family":"Ou","sequence":"additional","affiliation":[{"name":"Changsha County Xingsha Hospital, Changsha City, Hunan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8189-2543","authenticated-orcid":false,"given":"Ding","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Hand and Microsurgery, Xiangya Hospital Central South University, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,5,6]]},"reference":[{"key":"2025121600363767000_14.5.e078933.1","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11010136","article-title":"Insights into pathogenesis, nutritional and drug approach in sarcopenia: a systematic review","volume":"11","author":"Mellen","year":"2023","journal-title":"Biomedicines"},{"key":"2025121600363767000_14.5.e078933.2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/jcsm.12783","article-title":"Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis","volume":"13","author":"Petermann-Rocha","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2025121600363767000_14.5.e078933.3","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12993"},{"key":"2025121600363767000_14.5.e078933.4","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.743710","article-title":"Relationship between sarcopenia and cardiovascular diseases in the elderly: an overview","volume":"8","author":"He","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"2025121600363767000_14.5.e078933.5","doi-asserted-by":"crossref","DOI":"10.3390\/nu13124291","article-title":"Associated factors of sarcopenia in community-dwelling older adults: a systematic review and meta-analysis","volume":"13","author":"Gao","year":"2021","journal-title":"Nutrients"},{"key":"2025121600363767000_14.5.e078933.6","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28431"},{"key":"2025121600363767000_14.5.e078933.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.12.012"},{"key":"2025121600363767000_14.5.e078933.8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.5370"},{"key":"2025121600363767000_14.5.e078933.9","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1016\/j.cgh.2023.02.013","article-title":"Sarcopenia among patients with nonalcoholic fatty liver disease (NAFLD) is associated with advanced fibrosis","volume":"21","author":"Harring","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025121600363767000_14.5.e078933.10","doi-asserted-by":"crossref","DOI":"10.3390\/nu15040891","article-title":"Impact of sarcopenia on non-alcoholic fatty liver disease","volume":"15","author":"Iwaki","year":"2023","journal-title":"Nutrients"},{"key":"2025121600363767000_14.5.e078933.11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12072-019-09964-1","article-title":"Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"14","author":"Cai","year":"2020","journal-title":"Hepatol Int"},{"key":"2025121600363767000_14.5.e078933.12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2020.100197","article-title":"Adverse muscle composition is linked to poor functional performance and metabolic comorbidities in NAFLD","volume":"3","author":"Linge","year":"2021","journal-title":"JHEP Rep"},{"key":"2025121600363767000_14.5.e078933.13","article-title":"A critical appraisal of the definition of sarcopenia in patients with non-alcoholic fatty liver disease: pitfall of adjusted muscle mass by body weight","volume":"10","author":"Park","year":"2020","journal-title":"Life (Basel)"},{"key":"2025121600363767000_14.5.e078933.14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003583","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"18","author":"Page","year":"2021","journal-title":"PLoS Med"},{"key":"2025121600363767000_14.5.e078933.15","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.666507","article-title":"Risk factors for acute kidney injury in critically ill neonates: a systematic review and meta-analysis","volume":"9","author":"Hu","year":"2021","journal-title":"Front Pediatr"},{"key":"2025121600363767000_14.5.e078933.16","doi-asserted-by":"crossref","first-page":"232","DOI":"10.4093\/dmj.2021.0355","article-title":"Non-alcoholic fatty liver disease with sarcopenia and carotid plaque progression risk in patients with type 2 diabetes mellitus","volume":"47","author":"Cho","year":"2023","journal-title":"Diabetes Metab J"},{"key":"2025121600363767000_14.5.e078933.17","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2229139","article-title":"The association of sarcopenia and visceral obesity with lean nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus","volume":"2022","author":"Zhang","year":"2022","journal-title":"J Diabetes Res"},{"key":"2025121600363767000_14.5.e078933.18","doi-asserted-by":"crossref","first-page":"130","DOI":"10.5009\/gnl220041","article-title":"Association between sarcopenic obesity status and nonalcoholic fatty liver disease and fibrosis","volume":"17","author":"Song","year":"2023","journal-title":"Gut Liver"},{"key":"2025121600363767000_14.5.e078933.19","doi-asserted-by":"crossref","DOI":"10.1186\/s12877-020-01910-3","article-title":"Sarcopenia is associated with the presence of nonalcoholic fatty liver disease in Zhejiang province, China: a cross-sectional observational study","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Geriatr"},{"key":"2025121600363767000_14.5.e078933.20","first-page":"230","article-title":"Correlation between Sarcopenia and Nonalcoholic fatty liver disease in elderly patients with type 2 diabetes mellitus","volume":"14","author":"Z","year":"2021","journal-title":"Chinese Journal of Osteoporosis and Bone Mineral Research"},{"key":"2025121600363767000_14.5.e078933.21","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1089\/met.2021.0011","article-title":"Relationship between protein intake and sarcopenia in the elderly with nonalcoholic fatty liver disease based on the fourth and fifth Korea national health and nutrition examination survey","volume":"19","author":"Hong","year":"2021","journal-title":"Metab Syndr Relat Disord"},{"key":"2025121600363767000_14.5.e078933.22","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.diabet.2019.10.004","article-title":"Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes","volume":"46","author":"Seo","year":"2020","journal-title":"Diabetes Metab"},{"key":"2025121600363767000_14.5.e078933.23","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1159\/000506938","article-title":"Sarcopenia is a new risk factor of nonalcoholic fatty liver disease in patients with inflammatory bowel disease","volume":"38","author":"Kang","year":"2020","journal-title":"Dig Dis"},{"key":"2025121600363767000_14.5.e078933.24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/MEG.0000000000001475","article-title":"Sarcopenia assessed using bioimpedance analysis is associated independently with significant liver fibrosis in patients with chronic liver diseases","volume":"32","author":"Hyun Kim","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2025121600363767000_14.5.e078933.25","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2147\/COPD.S249534","article-title":"Sarcopenia is an independent risk factor for NAFLD in COPD: a nationwide survey (KNHANES 2008-2011)","volume":"15","author":"Hong","year":"2020","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2025121600363767000_14.5.e078933.26","doi-asserted-by":"crossref","first-page":"584","DOI":"10.14309\/ajg.0000000000000572","article-title":"Nonalcoholic fatty liver disease and sarcopenia are independently associated with cardiovascular risk","volume":"115","author":"Han","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"2025121600363767000_14.5.e078933.27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2020.100171","article-title":"Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease","volume":"2","author":"Golabi","year":"2020","journal-title":"JHEP Rep"},{"key":"2025121600363767000_14.5.e078933.28","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.clnu.2019.04.023","article-title":"Low muscle mass and low muscle strength associate with nonalcoholic fatty liver disease","volume":"39","author":"Gan","year":"2020","journal-title":"Clin Nutr"},{"key":"2025121600363767000_14.5.e078933.29","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1097\/MEG.0000000000001397","article-title":"Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA","volume":"31","author":"Wijarnpreecha","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2025121600363767000_14.5.e078933.30","first-page":"814","article-title":"Relationship between Sarcopenic obesity and non-alcoholic fatty liver disease","volume":"27","author":"Z","year":"2019","journal-title":"Chinese Journal of Prevention and Control of Chronic Non-Communicable Diseases"},{"key":"2025121600363767000_14.5.e078933.31","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.clnu.2017.11.021","article-title":"Nonalcoholic fatty liver disease and Sarcopenia in a Western population (NHANES III): the importance of Sarcopenia definition","volume":"38","author":"Peng","year":"2019","journal-title":"Clin Nutr"},{"key":"2025121600363767000_14.5.e078933.32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.7570\/jomes.2019.28.2.129","article-title":"Sarcopenia is significantly associated with presence and severity of Nonalcoholic fatty liver disease","volume":"28","author":"Chung","year":"2019","journal-title":"J Obes Metab Syndr"},{"key":"2025121600363767000_14.5.e078933.33","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/lt.25346","article-title":"Differing impact of sarcopenia and frailty in nonalcoholic steatohepatitis and alcoholic liver disease","volume":"25","author":"Bhanji","year":"2019","journal-title":"Liver Transpl"},{"key":"2025121600363767000_14.5.e078933.34","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/jbmr.3713","article-title":"Nonalcoholic fatty liver disease in the Rotterdam study: about muscle mass, sarcopenia, fat mass, and fat distribution","volume":"34","author":"Alferink","year":"2019","journal-title":"J Bone Miner Res"},{"key":"2025121600363767000_14.5.e078933.35","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5016091","article-title":"The relationship between NAFLD and sarcopenia in elderly patients","volume":"2018","author":"Zhai","year":"2018","journal-title":"Can J Gastroenterol Hepatol"},{"key":"2025121600363767000_14.5.e078933.36","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/jcm7100310","article-title":"The association between nonalcoholic fatty liver disease and CT-measured Skeletal muscle mass","volume":"7","author":"Choe","year":"2018","journal-title":"J Clin Med"},{"key":"2025121600363767000_14.5.e078933.37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jhep.2016.08.019","article-title":"Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis","volume":"66","author":"Koo","year":"2017","journal-title":"J Hepatol"},{"key":"2025121600363767000_14.5.e078933.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.02.051"},{"key":"2025121600363767000_14.5.e078933.39","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cld.2023.01.002","article-title":"Metabolic syndrome and its association with nonalcoholic steatohepatitis","volume":"27","author":"Bril","year":"2023","journal-title":"Clin Liver Dis"},{"key":"2025121600363767000_14.5.e078933.40","doi-asserted-by":"crossref","DOI":"10.1186\/s41043-023-00372-8","article-title":"Association of C-reactive protein with histological, elastographic, and sonographic indices of non-alcoholic fatty liver disease in individuals with severe obesity","volume":"42","author":"Jamialahmadi","year":"2023","journal-title":"J Health Popul Nutr"},{"key":"2025121600363767000_14.5.e078933.41","doi-asserted-by":"publisher","DOI":"10.1172\/JCI77812"},{"key":"2025121600363767000_14.5.e078933.42","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/j.2040-4603.2020.tb00136.x","article-title":"Role of skeletal muscle in insulin resistance and glucose uptake","volume":"10","author":"Merz","year":"2020","journal-title":"Compr Physiol"},{"key":"2025121600363767000_14.5.e078933.43","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.774030","article-title":"Impact of sarcopenia on the severity of the liver damage in patients with non-alcoholic fatty liver disease","volume":"8","author":"Zambon Azevedo","year":"2021","journal-title":"Front Nutr"},{"key":"2025121600363767000_14.5.e078933.44","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126627","article-title":"The evolving role of Fetuin-A in nonalcoholic fatty liver disease: an overview from liver to the heart","volume":"22","author":"Dogru","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2025121600363767000_14.5.e078933.45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174717","article-title":"Association of Leukocyte cell-derived Chemotaxin 2 (Lect2) with NAFLD, metabolic syndrome, and atherosclerosis","volume":"12","author":"Yoo","year":"2017","journal-title":"PLoS One"},{"key":"2025121600363767000_14.5.e078933.46","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00379.2020"},{"key":"2025121600363767000_14.5.e078933.47","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-020-02417-x"},{"key":"2025121600363767000_14.5.e078933.48","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/684965","article-title":"Myostatin activates the Ubiquitin-Proteasome and Autophagy-Lysosome systems contributing to muscle wasting in chronic kidney disease","volume":"2015","author":"Wang","year":"2015","journal-title":"Oxid Med Cell Longev"},{"key":"2025121600363767000_14.5.e078933.49","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.dld.2019.03.002","article-title":"Myostatin regulates the Fibrogenic phenotype of hepatic Stellate cells via C-Jun N-terminal kinase activation","volume":"51","author":"Delogu","year":"2019","journal-title":"Dig Liver Dis"},{"key":"2025121600363767000_14.5.e078933.50","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.112","article-title":"The metabolic basis of nonalcoholic steatohepatitis","volume":"3","author":"Chakravarthy","year":"2020","journal-title":"Endocrinol Diabetes Metab"},{"key":"2025121600363767000_14.5.e078933.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2017.11.001"},{"key":"2025121600363767000_14.5.e078933.52","first-page":"200","article-title":"Sarcopenia is the independent predictor of mortality in critically ill patients with cirrhosis","volume":"8","author":"Khan","year":"2022","journal-title":"J Clin Transl Res"},{"key":"2025121600363767000_14.5.e078933.53","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.971913","article-title":"Assessing causal relationships between sarcopenia and nonalcoholic fatty liver disease: a bidirectional Mendelian randomization study","volume":"9","author":"Zhao","year":"2022","journal-title":"Front Nutr"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-078933","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T08:36:49Z","timestamp":1765874209000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-078933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":53,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5,6]]},"published-print":{"date-parts":[[2024,5]]}},"alternative-id":["10.1136\/bmjopen-2023-078933"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-078933","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5]]}}}